160. Congenital ichthyosis Clinical trials / Disease details
Clinical trials : 42 / Drugs : 71 - (DrugBank : 21) / Drug target genes : 18 - Drug target pathways : 112
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR2200059272 | 2022-06-01 | 2022-04-27 | A Basket Trial of the Safety and Efficacy of Ixekizumab in Participants with Autoimmune Inflammatory Skin Diseases | A Basket Trial of the Safety and Efficacy of Ixekizumab in Participants with Autoimmune Inflammatory Skin Diseases | pityriasis rubra pilaris, hidradenitis suppurativa, Netherton syndrome, erythrokeratodermia variabilis and erythrokeratoderma progressive symmetrica | pityriasis rubra pilaris, Netherton syndrome, erythrokeratodermia variabilis and erythrokeratoderma progressive symmetrica:Ixekizumab at different doses in adults and juveniles with different body weight;hidradenitis suppurativa:Ixekizumab at different doses in adults and juveniles with different body weight; | Dermatology Hospital of Southern Medical University | NULL | Pending | Both | pityriasis rubra pilaris, Netherton syndrome, erythrokeratodermia variabilis and erythrokeratoderma progressive symmetrica:30;hidradenitis suppurativa:10; | Phase 2 | China |